In diabetes, abnormally activated CD4+ T cells increase the expression of peripheral blood inflammatory factors by secreting the cytokines interleukin-17 (IL-17) and interferon-γ (IFN-γ) [13]. Here, CD4 is linked to diabetes mellitus.